Junxiu Yu

Junxiu Yu

Auto-generated profile, based on publicly available information

Junxiu Yu

Department of Trauma-Emergency & Critical Care Medicine, Shanghai Fifth People’s Hospital, Fudan University

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2026 in Clinical Microbiology Reviews
Verified
Journal Article
Open access
JYJunxiu Yu
Junxiu Yu
WLWenweiran Li
Wenweiran Li
YXYajie Xu
Yajie Xu
JTjianguo tang
jianguo tang
SUMMARY: The human gut microbiotas constitute a complex microecosystem essential for host homeostasis. Among its metabolites, short-chain fatty acids (SCFAs) act as key signaling molecules linking microbial activity to host immunity and barrier function. Based on existing literature, we conducted a comprehensive analysis of the interaction between SCFAs and 11 key gut pathogens. These pathogens include bacteria (i.e., Staphylococcus aureus , Clostridioides difficile, Salmonella spp. , Campylobacter jejuni, Klebsiella pneumoniae, Vibrio cholerae ), fungi (i.e., Candida albicans ), and viruses (i.e., SARS-CoV-2, influenza virus, respiratory syncytial virus, rotavirus). In terms of antibacterial effects, SCFAs exhibit antibacterial activity against most gut microorganisms, but they support the colonization of a few species (i.e., Campylobacter jejuni ). Given the complex interactions between SCFAs and the gut microbiota, as well as their regulatory roles in infection, further investigation of the microbiota-SCFA axis is essential for developing effective strategies to prevent and treat infectious diseases. This review systematically summarizes the mechanism and clinical evidence of SCFAs in microbial infections to provide novel ideas for infectious disease management.